Page 33 - Htain Manual

Assessment in 1996. In 1999, National Institute for Health and Clinical Excellence (NICE) was

established to support the evidence-based decision making process in the National Health

Service in England.

Table 1. National Agencies for HTA internationally and their roles
AGENCY COUNTRY ROLE
Institute for Clinical Effectiveness and Health Policy ARGENTINA Consultative

Australian Safety and Efficacy Register of New Procedures AUSTRALIA Consultative
Institute of Technology Assessment AUSTRIA Consultative
Belgian Health Care Knowledge Center BELGIUM Consultative
ONTARIO,
Canadian Agency for Drugs and Technology in Health Consultative
CANADA

Agence d'Évaluation des Technologies et des Modes QUÉBEC,
Consultative
d'Intervention en Santé CANADA
Institute of Health Economics ALBERTA Consultative
Instituto Nacional de Higiene Epidemiologiay
CUBA Consultative
Microbiologia
Danish Centre for Evaluation and HTA (DACEHTA), DENMARK Consultative
Finnish Office for Health Care Technology Assessment
FINLAND Consultative
Helsinki

Comité d'Evaluation et de Diffusion des Innovations
FRANCE Consultative
Technologiques
German Agency for Health Technology Assessment at the
German Institute for Medical Documentation and GERMANY Consultative
Information
Health Economics and Health Technology Assessment
HUNGARY Consultative
Research Centre

Israeli Centre for Technology Assessment in Health Care ISRAEL Consultative
Health Statistics and Medical Technologies State Agency LATVIA Consultative
Mexican Institute of Social Security MEXICO Consultative
NEW
New Zealand Health Technology Assessment Consultative
ZEALAND
Norwegian Knowledge Centre for the Health Services NORWAY Consultative
Galician Agency for Health Technology Assessment
SPAIN Consultative
Santiago de Compostela
Center for Medical Technology Assessment SWEDEN REGULATORY
Swiss Network for Health Technology Assessment SWITZERLAND Consultative
Health Intervention and Technology Assessment Program THAILAND Consultative
Agency for Healthcare Research and Quality USA Consultative

National Institute for Health and Care Excellence England REGULATORY

21